This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Robert F. Friel Elected To Xylem Inc.’s Board Of Directors

Xylem Inc. (NYSE: XYL), a leading global water technology company, today announced the election of Robert F. Friel, chairman, president and chief executive officer of PerkinElmer, Inc. (NYSE: PKI), to its Board of Directors. His appointment to Xylem’s board is effective immediately.

Friel, 57, was named chief executive officer of PerkinElmer in February, 2008, and elected chairman of its Board of Directors in April, 2009. Headquartered in Waltham, Mass., PerkinElmer is a global technology leader providing diagnostic, life sciences research and analytical testing solutions with 2011 revenues of $1.9 billion. He joined PerkinElmer in 1999 as senior vice president and chief financial officer, and subsequently served in a series of executive financial and operating positions. Prior to joining PerkinElmer, Friel spent 19 years with AlliedSignal, Inc., now Honeywell International, in a number of global financial executive positions, and was ultimately named vice president and treasurer in 1996.

“Rob’s deep experience in global finance and operations will add valuable perspective to Xylem’s board as we continue to execute our growth strategies,” said Gretchen McClain, president and chief executive officer of Xylem Inc. “We are pleased to welcome him as a director and look forward to his future contributions.”

“It’s a great pleasure to welcome another accomplished and dynamic director to our board,” said Xylem Chairman Markos Tambakeras. “Rob’s years of experience and business insights will bring great value to Xylem.”

Friel earned a Bachelor of Arts degree in economics from Lafayette College and a Master of Science degree in taxation from Fairleigh Dickinson University. In addition to PerkinElmer, Friel also serves as a director at CareFusion Corporation (NYSE: CFN), a $3.5 billion medical equipment manufacturer, and is a member of the National Board of Trustees for the March of Dimes.

Friel’s election brings to 10 the number of directors on Xylem Inc.’s board.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs